去年，Bioventus Inc表現最佳的業務類別Pain Treatments的營收達到279.06M美元。United States的營收貢獻最高，去年達到502.10M美元。最近一個季度，截至2026-06-27，Bioventus Inc表現最佳的業務類別Pain Treatments的營收達到81.75M美元。United States的營收貢獻最高，達到134.47M美元。

業務

營業收入

佔比

年報

年報

單季報

Pain Treatments

Surgical solutions

Restorative Therapies

Pain Treatments and Joint Preservation

Bone grafts substitutes

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Pain Treatments

279.06M(49.12%)

261.29M(31.31%)

220.80M(30.12%)

--(--)

Surgical solutions

203.65M(35.85%)

189.25M(22.68%)

154.47M(21.07%)

141.16M(27.56%)

--(--)

Restorative Therapies

85.37M(15.03%)

122.74M(14.71%)

137.07M(18.70%)

154.63M(30.20%)

121.57M(28.21%)

88.62M(27.59%)

103.50M(30.43%)

121.03M(37.92%)

Pain Treatments and Joint Preservation

--(--)

261.29M(31.31%)

220.80M(30.12%)

216.32M(42.24%)

221.61M(51.43%)

171.18M(53.30%)

182.08M(53.53%)

155.58M(48.74%)

Bone grafts substitutes

--(--)

87.72M(20.36%)

61.36M(19.11%)

54.55M(16.04%)

42.57M(13.34%)

地區

營業收入

佔比

年報

年報

單季報

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

United States

502.10M(88.38%)

506.81M(88.41%)

449.86M(87.80%)

455.25M(88.90%)

387.55M(89.94%)

293.70M(91.45%)

305.07M(89.69%)

282.89M(88.63%)

International

65.99M(11.62%)

66.47M(11.59%)

62.48M(12.20%)

56.87M(11.10%)

43.34M(10.06%)

27.46M(8.55%)

35.07M(10.31%)

36.28M(11.37%)